Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 1,295,500 | 1,459,600 | 429,900 | 1,319,000 | 1,373,900 |
| Cost of Goods | 256,900 | 329,500 | -98,800 | 253,800 | 269,400 |
| Gross Profit | 1,038,600 | 1,130,100 | 528,700 | 1,065,200 | 1,104,500 |
| Operating Expenses | 776,000 | 742,200 | 330,200 | 663,600 | 645,400 |
| Operating Income | 263,500 | 388,400 | 197,700 | 402,400 | 459,500 |
| Other Income | 11,600 | 10,200 | 13,700 | 4,900 | 5,200 |
| Pre-tax Income | 275,100 | 398,600 | 211,400 | 407,300 | 464,700 |
| Income Tax | 20,900 | 58,100 | 10,900 | 63,800 | 58,300 |
| Net Income Continuous | 254,200 | 340,500 | 200,500 | 343,500 | 406,400 |
| Net Income Discontinuous | 51,300 | N/A | N/A | N/A | N/A |
| Minority Interests | -1,600 | N/A | N/A | N/A | N/A |
| Net Income | $307,100 | $340,500 | $398,400 | $343,500 | $406,400 |
| EPS Basic Total Ops | 0.51 | 0.56 | 0.66 | 0.55 | 0.65 |
| EPS Basic Continuous Ops | 0.42 | 0.56 | 0.33 | 0.55 | 0.65 |
| EPS Basic Discontinuous Ops | 0.09 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.50 | 0.56 | 0.65 | 0.55 | 0.65 |
| EPS Diluted Continuous Ops | 0.42 | 0.56 | 0.33 | 0.55 | 0.65 |
| EPS Diluted Discontinuous Ops | 0.08 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $299,600 | $423,600 | $233,100 | $437,800 | $493,600 |